Related Experiment Video
Updated: Jul 14, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
Treating the right patient at the right time: access to heart failure care
H Ross1, J Howlett, J Malcolm O Arnold
1Department of Medicine, University Health Network, University of Toronto, Toronto, Canada. Heather.Ross@uhn.on.ca
Insights
Timely access to heart failure care is crucial for improving patient outcomes and reducing mortality. This paper highlights data gaps and advocates for national benchmarks for heart failure disease management programs and physician access.
Area of Science:
- Cardiology
- Public Health
- Health Services Research
Background:
- Heart failure impacts over 500,000 Canadians, with 50,000 new diagnoses annually.
- The five-year age-adjusted mortality rate for heart failure is a significant 45%.
- Disease management programs show promise in improving heart failure patient outcomes, quality of care, and reducing costs and hospitalizations.
Purpose of the Study:
- To summarize available data on adverse events related to waiting times for heart failure care.
- To identify existing data gaps in heart failure management.
- To provide recommendations for timely access to acute and chronic heart failure care, including disease management programs and specialist physician access.
Main Methods:
- Literature review of existing data on heart failure.
- Analysis of adverse event risks associated with waiting times.
- Expert consensus on best practices for timely access to care.
Main Results:
- Significant mortality associated with heart failure in Canada.
- Evidence supports the benefits of disease management programs for heart failure.
- Lack of national benchmarks for cardiovascular care access, including heart failure services.
Conclusions:
- Urgent need for national benchmarks and targets for timely access to heart failure care.
- Addressing data gaps is essential for optimizing heart failure management.
- Timely access to heart failure disease management programs and physician care is critical for improving patient survival and quality of life.
Abstract:
Heart failure affects over 500,000 Canadians, and 50,000 new patients are diagnosed each year. The mortality remains staggering, with a five-year age-adjusted rate of 45%. Disease management programs for heart failure patients have been associated with improved outcomes, the use of evidence-based therapies, improved quality of care, and reduced costs, mortality and hospitalizations. Currently, national benchmarks and targets for access to care for cardiovascular procedures or office consultations do not exist. The present paper summarizes the currently available data, particularly focusing on the risk of adverse events as a function of waiting time, as well as on the identification of gaps in existing data on heart failure. Using best evidence and expert consensus, the present article also focuses on timely access to care for acute and chronic heart failure, including timely access to heart failure disease management programs and physician care (heart failure specialists, cardiologists, internists and general practitioners).
More Related Videos
12:45Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing
Published on: December 11, 2017
05:41Left Anterior Descending Coronary Artery Ligation for Ischemia-Reperfusion Research: Model Improvement via Technical Modifications and Quality Control
Published on: December 16, 2022
Related Concept Videos
Rheumatic Heart Disease III: Medical Management
Heart Failure IV: Classification and Diagnostic Evaluation
Heart Failure V: Medical Management
Heart Failure VI: Adjunct Therapies
Heart Failure VII: Nursing Interventions
Cardiomyopathy V: Interprofessional Care